ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Adult Health

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,806Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 15

$456K Total Retail Price of All Prescriptions

Rank: 1 out of 15

512 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 512 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

6% of this provider’s 8,676 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 538 439 1 3
HYDROCODONE-ACETAMINOPHEN 388 253 S3 2 4
OMEPRAZOLE 320 225 3 6
CARVEDILOL 316 224 4 1
FUROSEMIDE 292 243 5 5
LISINOPRIL 290 261 6 2
AMLODIPINE BESYLATE 278 203 7 7
LEVOTHYROXINE SODIUM 244 217 8 8
ZOLPIDEM TARTRATE 218 146 9 28
POTASSIUM CHLORIDE 215 194 10 13
AMITRIPTYLINE HCL 196 141 R 11 30
ATENOLOL 187 118 12 23
MELOXICAM 177 133 13 17
RANITIDINE HCL 173 104 14 34
GABAPENTIN 163 92 15 22
CLOPIDOGREL 156 139 16 12
TRAMADOL HCL 145 105 17 16
METFORMIN HCL 144 101 18 10
NEXIUM 144 94 18 19
GLYBURIDE-METFORMIN HCL 142 106 R 20 38
AZITHROMYCIN 137 91 21 20
FLUTICASONE PROPIONATE 135 91 22 31
ISOSORBIDE MONONITRATE ER 131 103 23 27
METOPROLOL TARTRATE 128 89 24 14
HYDROCHLOROTHIAZIDE 125 105 25 18
SPIRONOLACTONE 121 94 26 21
DONEPEZIL HCL 120 120 27 42
ENALAPRIL MALEATE 115 66 28 43
SERTRALINE HCL 111 77 29 44
CRESTOR 111 88 29 24
CITALOPRAM HBR 105 88 31 32
ATORVASTATIN CALCIUM 104 95 32 11
METOPROLOL SUCCINATE 103 91 33 35
GLIPIZIDE ER 103 67 33 47
TAMSULOSIN HCL 101 88 35 48
ALLOPURINOL 99 64 36 33
DICLOFENAC SODIUM 97 37 37 49
WARFARIN SODIUM 95 81 38 15
TRAZODONE HCL 93 40 39 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 74 40 36
PREMARIN 87 61 R 41 53
AMOX TR-POTASSIUM CLAVULANATE 81 52 42 54
PROMETHAZINE HCL 80 58 R 43 55
CEPHALEXIN 79 52 44 56
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 59 44 56
SPIRIVA 78 61 46 58
PRAVASTATIN SODIUM 76 54 47 9
ENALAPRIL-HYDROCHLOROTHIAZIDE 72 62 48 60
DOXAZOSIN MESYLATE 72 72 48 60
PROAIR HFA 70 55 50 63
CIPROFLOXACIN HCL 70 52 50 41
FLUOXETINE HCL 67 24 52 64
PAROXETINE HCL 67 50 52 64
LACTULOSE 66 56 54 66
LOSARTAN-HYDROCHLOROTHIAZIDE 66 65 54 66
LANTUS 65 51 56 68
PLAVIX 61 51 57 26
VENTOLIN HFA 61 27 57 39
LOSARTAN POTASSIUM 59 46 59 29
LIPITOR 58 49 60 71
GLIPIZIDE 56 49 61 73
FINASTERIDE 56 56 61 73
NIFEDIPINE ER 55 33 63 76
CARISOPRODOL 55 16 R 63 76
TRIAMTERENE-HCTZ 55 48 63 76
ALENDRONATE SODIUM 54 39 66 40
FAMOTIDINE 51 41 67 80
NITROFURANTOIN MONO-MACRO 51 35 67 80
ZETIA 50 33 69 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.